IN2012DN05279A - - Google Patents

Info

Publication number
IN2012DN05279A
IN2012DN05279A IN5279DEN2012A IN2012DN05279A IN 2012DN05279 A IN2012DN05279 A IN 2012DN05279A IN 5279DEN2012 A IN5279DEN2012 A IN 5279DEN2012A IN 2012DN05279 A IN2012DN05279 A IN 2012DN05279A
Authority
IN
India
Prior art keywords
potential
methods
acid
nutritional compositions
nutritional
Prior art date
Application number
Inventor
Kevin Burke Miller
Zamzam Kabiry Roughead
Jennifer Rae Mager
Douglad Richard Bolster
Norman Alan Greenberg
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN05279A publication Critical patent/IN2012DN05279A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Data Mining & Analysis (AREA)
  • Theoretical Computer Science (AREA)
  • Mathematical Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Databases & Information Systems (AREA)
  • Mathematical Analysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Computational Mathematics (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

Nutritional compositions having the potential to reduce metabolic acid load and methods of making and using the nutritional compositions are provided. In an embodiment the present disclosure provides methods of selecting and administering nutritional compositions to patients. The methods may include modifications to calculating a metabolic acid potential of a nutritional composition calculating a base content of a nutritional composition and subtracting the base content from the acid content to determine a potential renal acid load ('PRAL') value. The present disclosure also provides computer implemented processes for predicting PRAL values.
IN5279DEN2012 2009-12-22 2010-12-21 IN2012DN05279A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28892809P 2009-12-22 2009-12-22
US29668810P 2010-01-20 2010-01-20
US201061424070P 2010-12-17 2010-12-17
PCT/US2010/061444 WO2011087769A2 (en) 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential

Publications (1)

Publication Number Publication Date
IN2012DN05279A true IN2012DN05279A (en) 2015-08-07

Family

ID=44304885

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5279DEN2012 IN2012DN05279A (en) 2009-12-22 2010-12-21

Country Status (13)

Country Link
US (1) US20130129838A1 (en)
EP (1) EP2516007A2 (en)
JP (1) JP2013514812A (en)
CN (1) CN102753043A (en)
AU (1) AU2010341566A1 (en)
BR (1) BR112012018321A2 (en)
CA (1) CA2785262A1 (en)
IN (1) IN2012DN05279A (en)
MX (1) MX2012007300A (en)
PH (1) PH12012501150A1 (en)
RU (1) RU2012131125A (en)
SG (1) SG181619A1 (en)
WO (1) WO2011087769A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150150898A1 (en) * 2012-06-11 2015-06-04 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance and reducing exercise induced impairment of immune function
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
WO2014047497A1 (en) * 2012-09-21 2014-03-27 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
MX372881B (en) * 2012-12-14 2020-07-08 Hills Pet Nutrition Inc ANTI-AGING FOOD FOR PETS.
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CN105101812B (en) 2013-03-08 2018-04-10 艾斯姆食品公司 Rice Protein Supplements
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
US10130603B2 (en) 2013-11-05 2018-11-20 Colgate-Palmolive Company Methods and compositions for improving kidney function
WO2016154575A1 (en) * 2015-03-26 2016-09-29 Cambrooke Therapeutics, Inc. Aqueous ketogenic compositions
CN110868870A (en) 2017-05-12 2020-03-06 艾斯姆食品公司 Rice products and systems and methods for making same
IT202000008203A1 (en) * 2020-04-17 2021-10-17 D M F Dietetic Metabolic Food S R L NUTRITIONAL COMPOSITION FOR THE TREATMENT OF METABOLIC DISEASES
WO2025181327A1 (en) 2024-03-01 2025-09-04 Aarhus Universitet Quantification of renal acid-base excretion in people with short bowel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002204A1 (en) * 1990-01-26 1991-08-01 Westfalen Milchwerke DIET TABLE FOR PATIENTS WITH KIDNEY INSUFFICIENCY
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
AT408416B (en) * 1996-07-19 2001-11-26 Norbert Fuchs PHARMACEUTICAL OR DIETETIC COMPOSITIONS
JP2000264844A (en) * 1999-01-11 2000-09-26 Otsuka Pharmaceut Factory Inc Nutritional composition for patients with kidney disease
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US20090137459A1 (en) * 2005-11-21 2009-05-28 Katry Inversiones, S.L. Food Product for Enteral or Oral Nutrition

Also Published As

Publication number Publication date
AU2010341566A1 (en) 2012-07-12
US20130129838A1 (en) 2013-05-23
BR112012018321A2 (en) 2019-09-24
WO2011087769A2 (en) 2011-07-21
JP2013514812A (en) 2013-05-02
WO2011087769A3 (en) 2011-10-27
RU2012131125A (en) 2014-01-27
CN102753043A (en) 2012-10-24
PH12012501150A1 (en) 2012-10-22
SG181619A1 (en) 2012-07-30
MX2012007300A (en) 2012-07-04
EP2516007A2 (en) 2012-10-31
CA2785262A1 (en) 2011-07-21

Similar Documents

Publication Publication Date Title
IN2012DN05279A (en)
MX342423B (en) 6 -benzylphenyl- 2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients.
MX2021012876A (en) Novel anti-inflammatory agents.
EP4241767A3 (en) Novel lipids and compositions for the delivery of therapeutics
NZ620326A (en) Cd37 immunotherapeutic combination therapies and uses thereof
SG178984A1 (en) Novel pyrimidine and triazine hepcidine antagonists
PH12012502406A1 (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
GB2499924A (en) Public collaboration system
AU328419S (en) Cover for electronic equipment cabinet
MX2012004525A (en) Compounds.
MX2008008009A (en) Parenteral nutrition composition containing iron.
PH12013501773A1 (en) Nutritional compositions for increasing arginine levels and methods of using same
NZ601552A (en) Component display processing method and user equipment
EP2024133A4 (en) Improved alloy and anode for use in the electrowinning of metals
GB2500847A (en) Timed reading experience electronic book
TW200735863A (en) Dietary compositions for enhancing metabolism and reducing reactive oxygen species
WO2010028336A3 (en) Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
MX2011007222A (en) Nutritional composition for infants.
SG123793A1 (en) Low oxygen content alloy compositions
WO2007082048A3 (en) Ex vivo hyperpolarization of imaging agents
WO2008085921A3 (en) Methods for reduction of adipose tissue mass
MY151438A (en) Compositions and method for treatment of tumors
Assmann 111 THE PATIENT AT RISK FOR MYOCARDIAL INFARCTION AND STROKE: NEW PROCAM DATA
WO2010081622A3 (en) Food supplement for the treatment of neuropathies
MX2010010016A (en) Preparation of a pharmaceutical composition for increasing bone mineral density.